Bitcoin is on a rollercoaster ride this week. The price rose about $20,000 on some exchanges, but on others, it stayed around $16,000. Ryan Surber, Contributor for Seeking Alpha, and Daniel Roberts, Senior Writer at Yahoo Finance, take a look back at the week in cryptocurrency. Amid this roller coaster, big finance is rushing in to get a piece of cryptocurrency. Groups are now racing for bitcoin derivatives. Roberts argues the price of Bitcoin rose so much this week because the Chicago Board Options Exchange announced they will launch Bitcoin futures on December 10. The question now becomes, will futures begin Sunday night with CBOE, and what that will do to the price, says Roberts. Surber says his price target is $90,000 for Bitcoin over the mid-term. Roberts says he doesn't think this number is so crazy. When looking at the impact of small investors on this cryptocurrency, Surber says this market has just scraped the surface.

Share:
More In Business
Hard pass, Cold brew, Dad bod: Merriam-Webster adds 5,000 new words
Merriam-Webster has fully revised its popular “Collegiate” dictionary with over 5,000 new words. They include “petrichor,” “dumbphone” and “ghost kitchen.” Also “cold brew,” “rizz,” “dad bod,” “hard pass,” “cancel culture” and more.
Poll: More Americans think companies benefit from legal immigration
A new poll finds U.S. adults are more likely than they were a year ago to think immigrants in the country legally benefit the economy. That comes as President Donald Trump's administration imposes new restrictions targeting legal pathways into the country. The Associated Press-NORC Center for Public Affairs Research survey finds Americans are more likely than they were in March 2024 to say it’s a “major benefit” that people who come to the U.S. legally contribute to the economy and help American companies get the expertise of skilled workers. At the same time, perceptions of illegal immigration haven’t shifted meaningfully. Americans still see fewer benefits from people who come to the U.S. illegally.
Tylenol maker rebounds a day after unfounded claims about its safety
Shares of Tylenol maker Kenvue are bouncing back sharply before the opening bell a day after President Donald Trump promoted unproven and in some cases discredited ties between Tylenol, vaccines and autism. Trump told pregnant women not to use the painkiller around a dozen times during the White House news conference Monday. The drugmaker tumbled 7.5%. Shares have regained most of those losses early Tuesday in premarket trading.
Load More